National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 7/23/2021 release of VAERS data:

This is VAERS ID 288901

Case Details

VAERS ID: 288901 (history)  
Form: Version 1.0  
Sex: Female  
Location: Florida  
   Days after vaccination:0
Submitted: 2007-08-23
   Days after onset:19
Entered: 2007-08-24
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Other       Purchased by: Other
Symptoms: Arthralgia, Asthenia, Pruritus, Pyrexia, Urticaria
SMQs:, Anaphylactic reaction (broad), Angioedema (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Guillain-Barre syndrome (broad), Hypersensitivity (narrow), Arthritis (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness: Viral sore throat
Preexisting Conditions: Unknown
Diagnostic Lab Data: None
CDC Split Type: WAES0708USA02529

Write-up: Information has been received from a physician assistant concerning a female patient who in June 2007, was vaccinated with a first dose of Gardasil. On 04-AUG-2007, the patient was vaccinated with a second dose of Gardasil (Lot# 658100/0525U). Illness at the time included a sore throat (viral syndrome). On 07-AUG-2007 three days later, the patient developed hives, joint pain, was itchy, tenderness in joints, arthralgia, fever and weakness. On 09-AUG-2007, the patient came in to see the physician. The physician put the patient on steroids and loratadine (CLARITIN) (manufacturer unknown). No laboratory diagnostic studies were performed. At the time of this report, the patient was recovering. The nurse practitioner wasn''t sure if the patient''s symptoms were related to the viral syndrome or the vaccine. No product quality complaint was involved. Hives, joint pain, was itchy, tenderness in joints, arthralgia, fever and weakness were considered to be disabling. Additional information has been requested.

New Search

Link To This Search Result:

Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166